Biotech and Pharmaceuticals
‘Terrifying’: Why U.S. senator in top intel post wants more spying on Chinese companies
Go back a decade and most Americans had never heard of Huawei. Today, the Chinese telecom giant is a symbol of how quickly China can dominate a strategic technology sector and in the process create new national security and market threats for U.S. government and industry. Democratic Senator Mark Warner of Virginia, the top Democrat […]
Read More
RFK Jr.’s vaccine panel to vote on changing hepatitis B shot recommendation for babies
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. looks on as he attends a press conference to discuss health insurance reform, at the Department of Health and Human Services in Washington, D.C., U.S., June 23, 2025. Kevin Mohatt | Reuters Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee […]
Read More
White House releases more details on Trump’s October MRI, says results were ‘perfectly normal’
U.S. President Donald Trump speaks to reporters during travel to Washington, D.C., from Palm Beach International Airport, Florida, U.S., November 30, 2025. Anna Rose Layden | Reuters The White House on Monday released new details about President Donald Trump’s October MRI, offering a more comprehensive explanation for the procedure after questions about why the 79-year-old […]
Read More
U.S. announces zero tariff pharmaceutical deal with Britain
U.S. President Donald Trump and British Prime Minister Keir Starmer hold a press conference following their meeting at Chequers, near Aylesbury, Britain, Sept. 18, 2025. Kevin Lamarque | Reuters The United States announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology on Monday which will lead to Britain spending more […]
Read More
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the […]
Read More
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Drug pricing has emerged as a key topic to watch for pharmaceutical companies and investors in 2025. As President Donald Trump pushes for lower medicine prices for Americans, the sector is facing additional pricing pressure from a Biden-era law called the Inflation Reduction Act. The IRA, voted into law in 2022, allows the Centers for […]
Read More
Novo’s next-gen obesity drug shows positive results, heads to late-stage testing
The logo of Novo Nordisk is displayed at the 8th China International Import Expo. Sheldon Cooper | Lightrocket | Getty Images Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study. The drugmaker’s […]
Read More
Abortion pill makers brace for restrictions a year after Trump’s election
Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe […]
Read More
Eli Lilly hits $1 trillion market value, a first for a health-care company
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly reached a $1 trillion market capitalization on Friday, the first health-care company in the world to join the exclusive club dominated by tech firms. Eli Lilly briefly hit […]
Read More
Obesity-drugmaker Novo Nordisk helps drive Denmark’s fastest growth in years
Denmark’s economic growth accelerated in the third quarter, boosted by strong pharmaceutical exports, a key industry for the small Nordic country home to weight loss drugmaker Novo Nordisk. Denmark’s seasonally adjusted gross domestic product (GDP) grew by 2.3% in the third quarter, the largest quarter-on-quarter expansion since the fourth quarter of 2021, a preliminary reading […]
Read More